Page last updated: 2024-09-05

sorafenib and nvp bvu972

sorafenib has been researched along with nvp bvu972 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(nvp bvu972)
Trials
(nvp bvu972)
Recent Studies (post-2010) (nvp bvu972)
6,5207305,25111010

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)nvp bvu972 (IC50)
Chain A, Hepatocyte growth factor receptorHomo sapiens (human)0.014
Hepatocyte growth factor receptorHomo sapiens (human)0.014

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, M; He, J; Jiang, X; Jiang, Y; Li, J; Liu, J; Ouyang, L; Wang, J; Zhang, J; Zhang, S1

Reviews

1 review(s) available for sorafenib and nvp bvu972

ArticleYear
Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs.
    European journal of medicinal chemistry, 2016, Jan-27, Volume: 108

    Topics: Antineoplastic Agents; Drug Discovery; Humans; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyridines; Quinazolines; Quinolones; Receptors, Vascular Endothelial Growth Factor; Small Molecule Libraries

2016